TSLP promotes GATA3-expressing effector regulatory T cells via DC2 derived from transitional DCs

Area of Science:

• Immunology
• Cancer Biology
• Dendritic Cell Biology

Background:

• Thymic stromal lymphopoietin (TSLP) is known to drive type 2 helper T cell responses.
• TSLP's role in regulatory T cell (Treg) generation, particularly in skin cancer, is less understood.
• Regulatory T cells play a critical role in immune suppression within the tumor microenvironment.

Purpose of the Study:

• To investigate the mechanism by which TSLP influences regulatory T cell populations in cutaneous melanoma.
• To identify the specific dendritic cell (DC) subset involved in TSLP-mediated Treg induction.
• To characterize the molecular requirements for TSLP-driven Treg generation.

Main Methods:

• Utilized a mouse model with inducible TSLP expression in epidermal keratinocytes.
• Employed genetic tools and lineage tracing to track DC populations and Treg development.
• Conducted transcriptomic analysis, surface marker profiling, and functional assays to identify and characterize DCs.

Main Results:

• TSLP induces the generation and accumulation of GATA3-expressing effector regulatory T (eTreg) cells.
• This process is mediated by a specific migratory DC population expressing the co-stimulatory molecule OX40L.
• Identified transitional dendritic cell-derived DC2 as the key DC subset involved in promoting GATA3+ eTreg cells.

Conclusions:

• TSLP promotes immunosuppression in cutaneous melanoma by driving GATA3+ eTreg cells via a specific DC subset (DC2).
• This pathway highlights a previously unrecognized tolerogenic axis.
• The findings suggest potential conserved mechanisms in humans relevant to cancer and inflammation.